These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6807261)

  • 21. [Probucol in the treatment of hyperlipidemias].
    Feder D; Langer AL; Alexandrino E; Medeiros S; Lotto M; Valente O
    Arq Bras Cardiol; 1986 Feb; 46(2):77-80. PubMed ID: 3827649
    [No Abstract]   [Full Text] [Related]  

  • 22. N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
    Wågberg M; Jansson AH; Westerlund C; Ostlund-Lindqvist AM; Särnstrand B; Bergstrand H; Pettersson K
    J Pharmacol Exp Ther; 2001 Oct; 299(1):76-82. PubMed ID: 11561065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)].
    Mc Caughan D
    Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of probucol and clofibrate on hepatic cholesterol metabolism.
    Shand JH; West DW
    Biochem Soc Trans; 1994 May; 22(2):111S. PubMed ID: 7958182
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
    Tsujita M; Yokoyama S
    Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
    Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newer hypolipidemic compounds.
    Kritchevsky D
    Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Probucol, HDL and inverse transport of cholesterol].
    Med Clin (Barc); 1989 Oct; 93(13):22-3 p.. PubMed ID: 2695695
    [No Abstract]   [Full Text] [Related]  

  • 30. Probucol promotes functional reendothelialization in balloon-injured rabbit aortas.
    Lau AK; Leichtweis SB; Hume P; Mashima R; Hou JY; Chaufour X; Wilkinson B; Hunt NH; Celermajer DS; Stocker R
    Circulation; 2003 Apr; 107(15):2031-6. PubMed ID: 12681995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clofibrate, phthalates and probucol on ubiquinone levels.
    Aberg F; Zhang Y; Appelkvist EL; Dallner G
    Chem Biol Interact; 1994 Apr; 91(1):1-14. PubMed ID: 8194121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures.
    Seri K; Matsuo T; Asano M; Sato R; Kato T
    Arzneimittelforschung; 1978; 28(10):1711-2. PubMed ID: 582674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probucol, cholestyramine, and serum cholesterol.
    Mann JI
    Lancet; 1981 Aug; 2(8243):422. PubMed ID: 6115188
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine.
    McLean LR; Hagaman KA
    Biochim Biophys Acta; 1988 Apr; 959(3):201-5. PubMed ID: 3355846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B; Van Tol A; Fruchart JC; Auwerx J
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation of cholesterol metabolism in Ehrlich ascites tumour cells by dietary cholesterol, cholestyramine and probucol.
    Esmail A; Fears R
    Biochem Soc Trans; 1980 Oct; 8(5):545. PubMed ID: 7450213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.